Patent · US Active

5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative

US9926335B2 · kind B2 · utility

2Cited by

1References

4Claims

0Family size

Assignee

PULMOCIDE LIMITED · GB

Inventors

Simon Fraser Hunt · London, GB
Stuart Thomas Onions · Nottingham, GB
Vladimir Sherbukhin · Nottingham, GB
Euan Alexander Fraser Fordyce · Nottingham, GB
Peter John Murray · London, GB
Daniel William Brookes · London, GB
Kazuhiro Ito · London, GB
Peter Strong · London, GB

Key dates

Filing date	Jul 6, 2017
Grant date	Mar 27, 2018
Priority date	—
Expiry date	Jul 6, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.